UBS Maintains Buy on MetLife, Raises Price Target to $87
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Brian Meredith has maintained a Buy rating on MetLife (NYSE:MET) and increased the price target from $84 to $87.
January 10, 2024 | 2:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS analyst Brian Meredith reaffirmed a Buy rating on MetLife and raised the price target to $87, indicating a positive outlook on the stock.
The increase in price target by a reputable analyst like Brian Meredith suggests a bullish view on MetLife's future performance. This can positively influence investor sentiment and potentially lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100